QID 379099

Date Published: 2023-12-19

QID 379099: MobaTek MobaXterm Multiple Security Vulnerabilities

MobaXterm is an enhanced terminal for Windows with an X11 server, a tabbed SSH client and several other network tools for remote computing (VNC, RDP, telnet, rlogin). MobaXterm brings all the essential Unix commands to Windows desktop, in a single portable exe file which works out of the box.

CVE-2022-38337: When aborting a SFTP connection, MobaXterm before v22.2 sends a hardcoded password to the server. The server treats this as an invalid login attempt which can result in a Denial of Service (DoS) for the user if services like fail2ban are used.
CVE-2022-38336: An access control issue in MobaXterm before v22.2 allows attackers to make connections to the server via the SSH or SFTP protocols without authentication.

Affected Versions:
MobaTek MobaXterm before version 22.2

QID Detection Logic(Authenticated):
This checks for vulnerable version of MobaXtrem.exe file.

Successful exploitation of this Vulnerability allows attackers to make connections to the server via the SSH or SFTP protocols without authentication.

CVSS V3 rated as Critical - 9.1 severity.

CVSS V2 rated as Medium - 5 severity.

Solution

The vendor has issued a fix.
For more information visit MobaXterm

Vendor References

MobaXterm - mobaxterm.mobatek.net/download-home-edition.html

CVEs related to QID 379099

CVE-2022-38337 | CVE-2022-38336 |

Software Advisories

Advisory ID	Software	Component	Link
MobaXterm			mobaxterm.mobatek.net/download-home-edition.html

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].